ES2052646T3 - Solucion no acuosa de hidrocloruro de doxorubicina. - Google Patents

Solucion no acuosa de hidrocloruro de doxorubicina.

Info

Publication number
ES2052646T3
ES2052646T3 ES88111434T ES88111434T ES2052646T3 ES 2052646 T3 ES2052646 T3 ES 2052646T3 ES 88111434 T ES88111434 T ES 88111434T ES 88111434 T ES88111434 T ES 88111434T ES 2052646 T3 ES2052646 T3 ES 2052646T3
Authority
ES
Spain
Prior art keywords
aqueous solution
doxorubicin hydrochloride
water
aqueous
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88111434T
Other languages
English (en)
Inventor
Murray Arthur Kaplan
Joseph Ballard Dr Bogardus
Robert Kevin Perrone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2052646T3 publication Critical patent/ES2052646T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A SOLUCIONES NO ACUOSAS, ESTABLES, CONCENTRADAS DE HIDROCLORURO DE DOXORRUBICINA, QUE CONTIENEN ADEMAS ACIDO CITRICO Y UN ANTIOXIDANTE SELECCIONADO DE FORMALDEHIDO-VISULFITO SODICO, TERC-BUTILHIDROQUINONA Y ALFA-TOCOFEROL (VITAMINA E) EN UN DISOLVENTE QUE CONSISTE EN PROPILENGLICOL, 1,2-DIHIDROXIBUTANO O 1,3-DIHIDROXIPROPANO O MEZCLAS DE ESTOS DISOLVENTES CON AGUA. LAS SOLUCIONES TIENEN UNA VIDA DE ALMACENAMIENTO ACEPTABLE, MAYOR DE 18 MESES A TEMPERATURA AMBIENTE Y PUEDEN SER DILUIDAS CON AGUA U OTROS VEHICULOS PARENTERALES ACUOSOS PARA ADMINISTRACION PARENTERAL.
ES88111434T 1987-07-16 1988-07-15 Solucion no acuosa de hidrocloruro de doxorubicina. Expired - Lifetime ES2052646T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7418987A 1987-07-16 1987-07-16

Publications (1)

Publication Number Publication Date
ES2052646T3 true ES2052646T3 (es) 1994-07-16

Family

ID=22118210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88111434T Expired - Lifetime ES2052646T3 (es) 1987-07-16 1988-07-15 Solucion no acuosa de hidrocloruro de doxorubicina.

Country Status (11)

Country Link
EP (1) EP0299528B1 (es)
JP (1) JPS6438021A (es)
KR (1) KR920004096B1 (es)
AT (1) ATE82682T1 (es)
AU (1) AU615454B2 (es)
DE (1) DE3876160T2 (es)
DK (1) DK396188A (es)
ES (1) ES2052646T3 (es)
FI (1) FI883337L (es)
GR (1) GR3006383T3 (es)
PT (1) PT88015B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE87210T1 (de) * 1988-12-05 1993-04-15 Bristol Myers Squibb Co Doxorubicin-loesungen.
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
RU2065307C1 (ru) * 1994-12-13 1996-08-20 Александр Васильевич Тихонов Способ лечения первичного рака печени и набор для лечения первичного рака печени
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5946961A (en) * 1998-05-01 1999-09-07 Buhrke Industries, Inc. Web bowing apparatus
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
RU2134589C1 (ru) * 1998-12-22 1999-08-20 Зубов Дмитрий Львович Способ лечения первичного рака печени и набор для лечения первичного рака печени
US20150190509A1 (en) * 2012-08-03 2015-07-09 Mestex Ag Resiniferatoxin solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795492B (en) * 1978-10-20 1981-05-27 Lilly Co Eli Stable erythromycin solution
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
FI883337A7 (fi) 1989-01-17
ATE82682T1 (de) 1992-12-15
JPS6438021A (en) 1989-02-08
FI883337A0 (fi) 1988-07-13
DE3876160D1 (de) 1993-01-07
DK396188A (da) 1989-01-17
DK396188D0 (da) 1988-07-15
EP0299528A1 (en) 1989-01-18
FI883337L (fi) 1989-01-17
KR920004096B1 (ko) 1992-05-25
PT88015A (pt) 1989-06-30
AU615454B2 (en) 1991-10-03
AU1905188A (en) 1989-01-19
EP0299528B1 (en) 1992-11-25
PT88015B (pt) 1995-03-01
JPH0559093B2 (es) 1993-08-30
GR3006383T3 (es) 1993-06-21
KR890001570A (ko) 1989-03-27
DE3876160T2 (de) 1993-04-01

Similar Documents

Publication Publication Date Title
ES2093445T3 (es) Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
ES2085652T3 (es) Soluciones estabilizadas de peracido.
FR2633929B2 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
ES2033379T3 (es) Soluciones acuosas de clorhidrato de doxorubicina.
ES2007377A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica
ES8301626A1 (es) Un procedimiento mejorado para producir un preparado antimicrobiano de d-7(&-(4-hidroxi-6-metilnicotinamido)-4-hidroxi- fenilacetamido)-3-(1-metiltetrazol-5-il) tiometil-a3-cefem-4-carboxilato de sodio.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
DE3876160D1 (de) Nichtwaessrige loesung von doxorubicinhydrochlorid.
KR970704455A (ko) 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
ES2094227T3 (es) Procedimiento para la preparacion de una suspension acuosa.
ES8705463A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida
ES8706665A1 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
ES2120403T3 (es) Procedimiento de preparacion de derivados del acido 3,4-dihidroxibutirico opticamente activos.
ES8700226A1 (es) Un procedimiento para la preparacion en forma cristalina de una mezcla de sales diastereomericas del ester 1-pivaloiloxietilico de (s)-3-(3,4-dihidroxifenil)-2-metilalanina
ECSP910716A (es) Procedimiento para preparar un producto de celulosa oxidada, neutralizada y metodo de uso del mismo
DE68905577D1 (de) Doxorubicin-loesungen.
DK609889D0 (da) Vandig doxorubicinoploesning
IT1224503B (it) Derivati di acidi nucleici fisiologicamente attivi
ES2036722T3 (es) Un procedimiento para preparar una composicion farmaceutica que contiene un agente estabilizador.
ES512751A0 (es) "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares".
FR2621039B1 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
IT8521613A0 (it) Procedimento per l'ottenimento di una base organica azotata insolubile in acqua, partendo da una soluzione acquosa di bicarbonato di un metallo alcalino e di cloridrato di detta base eprocedimento di fabbricazione di bicarbonato di sodio.
FR2651778B1 (fr) Stabilisation des solutions aqueuses d'acide diethylenetriamine penta (methylene phosphorique) et de ses derives.
DK165667C (da) Injektionsoploesning indeholdende cholintheophyllinat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 299528

Country of ref document: ES